eChapters

Using the FAO criteria, Bargur and Siri cattle breeds and Attapadi goat breeds were categorized under vulnerable status of risk; Krishna Valley, Mewati, Pullikulam and Punganur cattle breeds, Chilika and Toda buffalo breeds and Karnah and Poonchi sheep breeds under endangered status of under risk and Vechur cattle under critical status of risk. All these breeds need immediate steps for rescue by using suitable conservation methodology. Breed-wise census should be continued in future so that trends in breed populations may also be estimated for fine tuning of risk assessment of breeds.

Rate of inbreeding in Indian livestock breeds: The rate of inbreeding estimated for different breeds of cattle was well below 0.5% (needed for a breed ‘not at risk’) except for Mewati (1.193%), Pullikulam (0.72%) and Vechur (17.893%). The rate of inbreeding in buffalo breeds was also well below 0.5% except in Chilika buffalo, where it was 0.731%. The rate of inbreeding of these breeds may be reduced by increasing the number of breeding males and in Vechur also the breeding females. The rate of inbreeding in all the breeds of sheep (Indian or exotic), goat and pig were estimated to be less than 0.5%. In these species, a good balance of breeding males and females is always expected.

ALL MATTER IS IN MOTION

Everything moves:

In the atom electrons rotate around the nucleus

In gases, liquids and even solids molecules move away from other molecules

An accumulation of matter (i.e., a baseball) can move as a unit

The average velocity of movement is the distance travelled divided by the time

Bodies in motion have energy; the faster the velocity the more energy

Introduction

The key factor of sustainability in the animal sector depends upon genetic improvement in domestic livestock. There are many reproductive and molecular biotechnologies used for the genetic improvement of domestic livestock and they are synergistically coupled with the breeding program in distinct breeding targets. With the help of gene editing techniques (e.g. CRISPR etc.). To improve the specific traits of interest scientists can add, delete or replace the nucleotides (e.g. milk production, meat production, disease resistance, etc.) in less than one generation. Gene editing with the conventional breeding program in livestock is an important factor for genetic improvement for increasing the rate of genetic gain. In the present topic, here, we delved into the most important reproductive and molecular technologies used in livestock genetic improvement, as well as the most effective ways for incorporating gene editing into existing genetic improvement programmes and targeting specific traits for enhancement. The improvement in genetic level is a most powerful part of sustainable animal development because it is permanent and the effects are long-lasting and cumulative. Genetic advancements produced in one generation are passed on to the following, unlike dietary and animal health treatments, which are a continuous process. The many livestock operations that involve chemical and mechanical methods such as dehorning requires time, worker, money, animal safety, etc., but their genetic alternation of the concerned gene for the polled or hornless condition can exclude the requirement of physical dehorning. (Gottardo et al. 2011; Tompson et al. 2017).

16.1 Entering Biological Data into Computer

After the forms have been designed, the database in ready for entry of biological data. Biological data is entered one record at a time. To enter the biological data, the user issues a command, which calls up and displays the appropriate form with blank fields. The user then keys in the data for each field in the appropriate spaces. In this manner, the user enters the data for the first record, then for the second record, and so on. In most database systems, the records are automatically assigned a number as they are entered.

16.2 Saving Biological Data into Computer

While entering data into the fields, the tab key or enter key is usually used to move to the next field. Pressing enter or tab key in the last field on the form saves the record in the database and moves to a new, blank form for the next record to be entered. In addition to using the tab or enter key to move forward through fields, one can directly go to any field on the form at any time by clicking on it with the mouse.

Carbohydrates (glucose) are the primary energy source for a body; when digested, glucose is the end product in human beings and simple stomach animals, but it yields volatile fatty acids in ruminants. Precise regulation of levels of blood sugars/glucose in the body is the net result of various processes like digestion, absorption, and metabolism operating under the interaction of various a) enzymes and b) hormones secreted by the different organs of the body. An abnormal secretion of any of the enzymes or hormones associated with the metabolism of carbohydrates disrupts the precise regulation of blood sugar, leading to various disorders.
14.1 Enzyme Deficiency and Disorders in Carbohydrate Metabolism
Usually, various enzymes are involved in the breakdown of carbohydrates, and if their secretion is insufficient, missing, or does not work correctly, it leads to different disorders.
I. Glycogen storage diseases (GSDs, glycogenosis, and dextrinosis)
Glucose is needed by the cells for the generation of energy and other cellular activities. If glucose happens to be in excess, it is stored as glycogen, mainly in the liver and muscles, for future needs. The stored glycogen can be converted back to glucose when the need arises. Many enzymes are related to this interconversion of glucose and glycogen. Deficiencies of one or more enzymes may lead to abnormal glycogen metabolism, leading to glycogen accumulation of normal or abnormal chemical structure in tissue, collectively called glycogen storage diseases (GSDs). Roman numerals identify different types of glycogen storage conditions. They are also classified under various categories like inherited metabolic diseases, autosomal recessive type, and X-linked type (VIII/IX type).

Enzymes are biological catalysts that regulate biochemical reactions and control metabolic pathways. This chapter explains how metabolomics can contribute to the discovery and functional characterization of enzymes by identifying changes in metabolite concentrations associated with enzymatic activity. Comparative metabolomics, gene knockout experiments, stable-isotope labeling, and multi-omics integration are discussed as approaches for linking metabolites with enzyme functions. Analytical platforms such as GC–MS, LC–MS, and NMR, together with databases including KEGG, BRENDA, HMDB, and METLIN, support metabolite identification and pathway analysis. The chapter also considers experimental validation, bioinformatics, challenges associated with unknown metabolites, and future applications involving artificial intelligence and computational biology.

Early and accurate diagnosis of disease is of prime importance for both the successful treatment of the patient and in limiting the spread of disease in the community. It is in this context that immunodiagnostic methods are now being used extensively since they can be extremely sensitive and highly specific. Among the most successful methods are those utilizing labelled antibodies or antigens. Examples of these are immunofluorescence in which antibodies labelled with fluorescent dyes are utilized and radioimmunoassay in which antigens or antibodies are labeled with isotopes. Both of these procedures have proved to be of great value for particular purposes.

ENZYMES

Enzymes are the heart of Biochemistry

Protein based catalysts.

Enormously effective catalysts: typically enhance rates by 10⁶ to 10¹² fold.

Operate under mild conditions: 0 - 100 °C (or perhaps even 300+ °C for some bacteria in deep ocean), 20 - 40 °C for most organisms; and low pressures (atmospheric).

Very specific: Generally catalyze reaction for a very restricted group of molecules, sometimes for a single naturally occurring molecule of a single chirality.

True/False

Q.1.    The purpose of most medical research is to identify the causes of disease and search out the ways to prevent or cure them.
Q.2.    Now a day, epidemiology has become a basic science for public health
Q.3.    The studies of diagnostics therapeutic and prognostic procedures have successfully incorporated into growing stream of “Clinical Epidemiology”.

Escherichia coli is an important model organism for studying microbial metabolism, metabolic regulation, and metabolic engineering. This chapter introduces the use of metabolomics to investigate the metabolic architecture and physiological responses of E. coli. It examines metabolite profiling, central carbon metabolism, metabolic pathways, environmental responses, and metabolic flux analysis. The chapter explains how metabolomic data can reveal changes in cellular metabolism and support the identification of pathway bottlenecks and regulatory mechanisms. Applications in microbial biotechnology, recombinant production, metabolic engineering, and optimization of fermentation processes are considered. The chapter demonstrates how E. coli serves as a useful experimental system for connecting metabolite changes with cellular function.

This chapter outlines fundamental molecular biology protocols essential for genomic analysis and molecular characterisation. Modern molecular biology relies heavily on precise analytical techniques for studying genetic material. Hence, this section presents a typical workflow encompassing nucleic acid extraction, amplification, and subsequent analysis. These methodologies are fundamental to various applications in molecular biology, including phylogenetic analysis, gene expression studies, and molecular diagnostics.
The chapter covers four core molecular biology and bioinformatics techniques, each building upon the previous:
1. Genomic DNA Extraction: Protocols for efficient isolation of DNA from biological samples. This encompasses cell lysis, protein denaturation, and nucleic acid purification through standard separation techniques. The quality and purity of extracted DNA significantly influences downstream applications.
2. Primer Design with Primer3: In silico design of oligonucleotide primers for PCR amplification. This section covers primer design parameters including optimal melting temperature (Tm), GC content, primer length, and considerations for avoiding secondary structures and primer-dimer formation.

The establishment of a technology transfer office is an important and complex process for an organization. It needs careful planning to ensure its long-term sustainability. Before establishing a TTO, it is essential to evaluate whether institution’s core mission includes research commercialization, and if the volume and quality of its research output justify the need for an inhouse TTO. For institutions that may not meet all criteria, those institutions can collaborate or outsource for TTO services. It is also important to decide about its operational scope, funding, management, and for what kind of issues the office should develop a policy. There is no “right” way to set up a TTO, but successful TTO does require considering some key issues. This chapter outlines key steps and considerations for establishing a TTO. It also explains what physical infrastructures are needed, manpower, outlines the responsibilities and powers of TTOs.
2.1 Evaluating the need for a TTO
Establishing a TTO is an important step for any research focused organization. But before initiating a planning process for a new TTO, the organization must review its relevance by considering a few fundamental points:
Key considerations for institutions
1. Is institution’s mission focused on “research commercialization” If an institute’s primary mission is education, or it does not support research it might not be justified to create a TTO. For such institutions, it usually makes better sense to seek alternative solutions to the occasional technology transfer without the expense of a formal office. But institutions with strong research commercialization focus, a TTO has the ability to contribute meaningfully to the mission. The Association of University Technology Managers (AUTM), USA has identified following key motivations for initiating academic technology transfer:

The cytological insult due to exposure of different environmental pollutant viz. pesticides, herbicides etc. impose great loss to the vitality and health of the individuals. The basic pathophysiological distrubances following the expo sure of these deterrents to the different visceral organs leads to dysfunction of these organs. Imbalance between body’s antioxidant defense and peroxidation of the lipid layer of cells’ causing free radical generation is defined as Oxidative stress. Free radicals are the molecules or entity that contains one or more than one unpaired electron. Pathophysiology of several diseases are associated with the generation of oxidative insult and many xenobiotics associated toxicity are also a result of oxidative damage and generation of reactive oxygen species and reactive nitrogen species. Alzheimer’s Disease is one of the fine example of oxidative damage associated neuronal degeneration.

Oxidative stress can be estimated using following parameters:

1. Lipid peroxidation (Paula et al., 2005)

2. Reduced glutathione (Sedlak and Lindsay, 1968)

3. Superoxide dismutase (Madesh and Balasubramanian, 1998)

4. Catalase (Aebi, 1983)

AI-enabled livestock technologies can improve productivity, health monitoring, animal welfare and environmental performance, but they also raise significant ethical and governance concerns. This chapter examines data ownership, privacy, algorithmic bias, transparency, accountability, cybersecurity, socioeconomic inequality and animal well-being. Precision livestock systems continuously monitor animals through sensors, computer vision, machine learning and IoT networks, enabling preventive decisions and automated interventions. However, excessive dependence on algorithms may reduce human oversight and treat animals merely as data-producing units. The chapter advocates an interdisciplinary framework for responsible AI that aligns innovation with animal-welfare standards, farmer interests, social values, equitable access, regulatory requirements and long-term environmental sustainability.

Introduction
The use of animals in scientific research has been a cornerstone of medical advancements for decades. However, this practice has also been the subject of intense ethical debate. This lecture explores the necessity of animal experimentation, the ethical considerations involved, and the regulatory frameworks in place to ensure the humane treatment of laboratory animals.
The Need for Laboratory Animals
Animal experimentation has played a crucial role in numerous medical breakthroughs. The importance of laboratory animals in research cannot be overemphasized. Among the various purposes for which humans use animals, experimentation involves relatively few animals and serves a noble purpose in advancing scientific knowledge and human health.
Laboratory animals are invaluable in the drug development process for several reasons:
• Similarity to human organ systems, metabolism, and enzyme functions.
• Suitability as alternatives to human subjects.
• Small size and ability to be reared in controlled environments.
• High reproductive rates.
• Potential for genetic purity, leading to reproducible and reliable results.
The Importance of Animal Welfare
While the benefits of animal experimentation are clear, it’s equally important to consider the ethical implications of using animals for research. The concept of animal welfare is embedded in the Indian Constitution, which states that it is the duty of every citizen “to protect and improve the natural environment including forests, rivers, lakes and wildlife, and to have right compassion for the living creatures” (Article 51 A (g)). This ethical consideration for animals has been emphasized by philosophers, spiritual leaders, and scientists throughout history:

Introduction

Structural changes in host cells by the viral infection is referred as cytopathic effect (CPE) and the responsible virus is called cytopathogenic virus. As a virus hijacks a cell to make copies of itself, the cell goes through distinct changes in its chemistry and structure. These effects are easiest to see in lab grown cell cultures. The severity of the damage caused by the virus depends on the specific virus itself, the type of cell it infects, how many viruses infect each cell (MOI), and other factors.

The early stages of this damage, called cytopathic effects (CPE), can be spotted directly under a microscope without any dyes or special treatments. While various types of CPE exist in living cells, some signs of viral infection, like inclusion bodies, require staining the cells to be visible. We can classify viruses based on how quickly they cause visible damage (cytopathic effect) in cell cultures. Viruses are typically considered slow if it takes 4-5 days to see this effect in cultures with a low starting dose of virus (MOI). On the other hand, viruses are considered fast if the damage shows up in just 1-2 days under the same conditions. It is important to note that at a high MOI all CPE can occur rapidly. So all decisions about rate of CPE appearance should be based on the lowest MOI that produces CPE

Performance metrics and indicators
Traditionally, in the past, TTOs’ performance was measured in monetary terms, such as universities’ revenues derived through commercialization. The methodology, however, is prone to shortcomings, in light of the fact that various TTOs do not receive significant amounts of financial proceeds through their technology transfers. In addition, relying on income does not depict a TTO’s true potential, in light of the fact that it does not account for the total range of outputs of research and commercialization opportunities. Recognizing these limitations, academics have found innovative ways to measure TTO efficiency, such as monetary and non-monetary indicators. Financial indicators typically entail measurable outcomes such as number of signed licenses, income from licenses, royalties collected, equity income, and number of spin-offs or startups created. These are actual gauges of the economic returns from commercialization efforts, and in the majority of instances are used in the context of benchmarking the performance of a TTO in a comparative context, perhaps against peer institutions or industry averages. Non-financial indicators consist of royalty distributions to academics, having an integral role in encouraging academics to participate in commercialisation activity. By incorporating monetary and non-financial metrics, universities might have an enhanced, comprehensive evaluation system for their TTOs. Such evaluation is sure to ensure assessment extends beyond short-run monetary metrics and looks to incorporate several organization, institutional, and research-oriented determinants in driving successful technology transfer.

Burn wounds are considered to be one of the most devastating kinds of trauma that affect the physical, physiological and psychological well being of an individual. Based on the depth of the affected area, burn wound is divided into three categories: first degree (superficial), second degree (partial) and third degree (full thickness). Extensive and deep burns result in scar formation and subsequent deformation of the affected part. Healing of burn wound involves several interrelated and overlapping stages such as inflammatory, proliferative and remodeling phases. The interaction of a variety of mediators, cells and extracellular matrix proteins are involved in this three phases of healing.

Burn wound therapy has been performed in various ways such as bioengineered skin grafts and administration of growth factors. Small intestinal sub-mucosa (SIS) is a resorbable xenogenic bioscaffold that has induced constructive remodeling in variety of animal models. It is unique from other acellular matrices as it contains few growth factors such as fibroblast growth factor (FGF) and transforming growth factor (TGF) that play a role in the regenerative process. Chitosan is currently proposed to be one of the most promising polymers in wound dressing development and it accelerates wound healing. Epidermal growth factor is known to stimulate growth of keratinocytes in vitro, thus it might be expected to promote wound healing.

In this chapter efficacy of Chitosan and porcine acellular small intestinal sub-mucosal (SIS) matrix seeded with bone marrow derived mesenchymal stem cells (BM-MSCs) and recombinant murine epidermal growth factor (m-EGF) on healing of full thickness burn wound in rat model is described.